Philips AI DeviceGuide Gets FDA Approval for Cardiac Use

Saturday, March 28, 2026YuvrajView original

Regulatory clearance has been secured by Philips from the U.S. Food and Drug Administration for EchoNavigator R5.0 with DeviceGuide, an artificial intelligence-based software developed to assist physicians during minimally invasive mitral valve repair procedures. Designed to address the technical complexity of these interventions, the platform delivers real-time visualization and procedural guidance. The advancement reinforces the […]

The post Philips AI DeviceGuide Gets FDA Approval for Cardiac Use first appeared on HHM Global | B2B Online Platform & Magazine.